Using 'co-dependence' between genes to kill treatment-resistant tumor cells
William Hahn, MD, PhD, describes research findings that suggest a new way to target a hard-to-treat cancer gene: by attacking a more vulnerable co-dependent gene. Hahn also talks about "synthetic lethality" and possible areas of future cancer research.
Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells
To view this video "full-screen," click the button in the lower right of the player.
